Position history for SANDS CAPITAL MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN
SANDS CAPITAL MANAGEMENT, LLC holds 3.2M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $67.3M as of 2026-Q1. The position was decreased (-7.8% shares). RARE represents 0.3% of SANDS CAPITAL MANAGEMENT, LLC's portfolio.
Current Value
$67.3M
Current Shares
3.2M
Total Value Change
-$152.7M
Total Shares Change
-2.1M
Other major holders of RARE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 3.2M |
-7.8% |
| $67.3M |
| 0.3% |
| $22.07 |
0 |
| 2025-Q4 | Decreased | 3.5M | -7.5% | $80.2M | 0.2% | $22.78 | 0 |
| 2025-Q3 | Decreased | 3.8M | -4.4% | $113.4M | 0.3% | $30.36 | 0 |
| 2025-Q2 | Decreased | 3.9M | -5.3% | $143.4M | 0.4% | $36.52 | 0 |
| 2025-Q1 | Decreased | 4.2M | -3.1% | $150.8M | 0.5% | $37.82 | 0 |
| 2024-Q4 | Decreased | 4.3M | -16.0% | $180.8M | 0.5% | $42.27 | 0 |
| 2024-Q3 | Decreased | 5.1M | -4.4% | $284.3M | 0.9% | $54.43 | 0 |
| 2024-Q2 | Increased | 5.4M | +38.7% | $220.1M | 0.6% | $41.10 | 57 |